Table 2.

MicroRNA	Sequence	P value	Fold change (patients/control)	Regulation
(a) Plasma miRNAs upregulated in psoriasis patients versus healthy subjects
hsa-miR-1271-5p	CUUGGCACCUAGCAAGCACUCA	0.0005695	3.31	Up
hsa-miR-299-5p	UGGUUUACCGUCCCACAUACAU	0.0006351	12.54	Up
hsa-miR-760	CGGCUCUGGGUCUGUGGGGA	0.001499	5.21	Up
hsa-miR-7-5p	UGGAAGACUAGUGAUUUUGUUGU	0.0022822	2.68	Up
hsa-miR-92b-3p	UAUUGCACUCGUCCCGGCCUCC	0.0045117	3.17	Up
hsa-miR-130b-5p	ACUCUUUCCCUGUUGCACUAC	0.0054175	2.43	Up
hsa-miR-510-5p	UACUCAGGAGAGUGGCAAUCAC	0.0155792	9.3	Up
hsa-miR-224-3p	AAAAUGGUGCCCUAGUGACUACA	0.015879	3.68	Up
hsa-miR-218-5p	UUGUGCUUGAUCUAACCAUGU	0.0167446	5.52	Up
hsa-miR-379-3p	UAUGUAACAUGGUCCACUAACU	0.0267967	3.13	Up
hsa-miR-761	GCAGCAGGGUGAAACUGACACA	0.033785	2.41	Up
hsa-miR-10b-3p	ACAGAUUCGAUUCUAGGGGAAU	0.0344881	4.04	Up
hsa-miR-624-5p	UAGUACCAGUACCUUGUGUUCA	0.0364547	2.74	Up
hsa-miR-577	UAGAUAAAAUAUUGGUACCUG	0.044155	3.05	Up
hsa-miR-935	CCAGUUACCGCUUCCGCUACCGC	0.0455152	4.76	Up
(b) Plasma miRNAs downregulated in psoriasis patients versus healthy subjects
hsa-miR-665	ACCAGGAGGCUGAGGCCCCU	0.0003116	0.065	Down
hsa-miR-320d	AAAAGCUGGGUUGAGAGGA	0.0023854	0.42	Down
hsa-miR-10b-5p	UACCCUGUAGAACCGAAUUUGUG	0.0109296	0.43	Down
hsa-miR-1260a	AUCCCACCUCUGCCACCA	0.0121104	0.42	Down
hsa-miR-362-3p	AACACACCUAUUCAAGGAUUCA	0.0130663	0.49	Down
hsa-miR-214-3p	ACAGCAGGCACAGACAGGCAGU	0.0169923	0.37	Down
hsa-miR-30a-5p	UGUAAACAUCCUCGACUGGAAG	0.0170545	0.37	Down
hsa-let-7b-3p	CUAUACAACCUACUGCCUUCCC	0.0235985	0.45	Down
hsa-miR-638	AGGGAUCGCGGGCGGGUGGCGGCCU	0.0240685	0.36	Down
hsa-miR-320c	AAAAGCUGGGUUGAGAGGGU	0.0241893	0.39	Down
hsa-miR-504-5p	AGACCCUGGUCUGCACUCUAUC	0.0248942	0.21	Down
hsa-miR-100-5p	AACCCGUAGAUCCGAACUUGUG	0.0254685	0.36	Down
hsa-miR-765	UGGAGGAGAAGGAAGGUGAUG	0.0363717	0.24	Down
hsa-miR-887-3p	GUGAACGGGCGCCAUCCCGAGG	0.038367	0.23	Down
hsa-miR-1207-5p	UGGCAGGGAGGCUGGGAGGGG	0.0478966	0.13	Down